These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18261995)

  • 41. Oxidative stress and diabetes mellitus.
    Yang H; Jin X; Kei Lam CW; Yan SK
    Clin Chem Lab Med; 2011 Nov; 49(11):1773-82. PubMed ID: 21810068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antioxidant paradox in diabetes mellitus.
    Sheikh-Ali M; Chehade JM; Mooradian AD
    Am J Ther; 2011 May; 18(3):266-78. PubMed ID: 19797943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impairment of calcium ATPases by high glucose and potential pharmacological protection.
    Horáková L; Strosova MK; Spickett CM; Blaskovic D
    Free Radic Res; 2013 Aug; 47 Suppl 1():81-92. PubMed ID: 23710650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of advanced glycosylation end products in the pathogenesis of hypertension].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2003; 60(9):585-7. PubMed ID: 15065338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
    Khalifah RG; Baynes JW; Hudson BG
    Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway.
    Cao W; Chen J; Chen Y; Chen S; Chen X; Huang H; Liu P
    Arch Biochem Biophys; 2015 Aug; 580():112-20. PubMed ID: 26163748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid glycation and protein glycation in diabetes and atherosclerosis.
    Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
    Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders.
    Stefano GB; Challenger S; Kream RM
    Eur J Nutr; 2016 Dec; 55(8):2339-2345. PubMed ID: 27084094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis.
    Chen S; Yin L; Xu Z; An FM; Liu AR; Wang Y; Yao WB; Gao XD
    Neurosci Lett; 2016 Jan; 612():193-198. PubMed ID: 26679229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.
    Williams ME; Bolton WK; Khalifah RG; Degenhardt TP; Schotzinger RJ; McGill JB
    Am J Nephrol; 2007; 27(6):605-14. PubMed ID: 17823506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of advanced glycation end products and its receptor on oxidative stress in diabetic wounds].
    Niu YW; Miao MY; Dong W; Dong JY; Cao XZ; Lu SL
    Zhonghua Shao Shang Za Zhi; 2012 Feb; 28(1):32-5. PubMed ID: 22490537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of nonenzymatic glycation and oxidative stress on the development of complicated diabetic cataracts].
    Sisková A; Wilhelm J
    Cesk Fysiol; 2000 Feb; 49(1):16-21. PubMed ID: 10953502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products.
    Kang Z; Li H; Li G; Yin D
    Amino Acids; 2006 Feb; 30(1):55-61. PubMed ID: 15990947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging.
    Monnier VM
    Biochem J; 2006 Oct; 399(2):e11-3. PubMed ID: 16987105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design.
    Khalifah RG; Chen Y; Wassenberg JJ
    Ann N Y Acad Sci; 2005 Jun; 1043():793-806. PubMed ID: 16037307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Singlet-oxygen-mediated amino acid and protein oxidation: formation of tryptophan peroxides and decomposition products.
    Gracanin M; Hawkins CL; Pattison DI; Davies MJ
    Free Radic Biol Med; 2009 Jul; 47(1):92-102. PubMed ID: 19375501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of oxidative stress in pathogenesis of diabetic microangiopathies].
    Araki E; Nishikawa T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():73-8. PubMed ID: 15999688
    [No Abstract]   [Full Text] [Related]  

  • 58. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells.
    Guimarães EL; Empsen C; Geerts A; van Grunsven LA
    J Hepatol; 2010 Mar; 52(3):389-97. PubMed ID: 20133001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of carnosine on methylglyoxal-induced oxidative stress in rats.
    Yılmaz Z; Kalaz EB; Aydın AF; Soluk-Tekkeşin M; Doğru-Abbasoğlu S; Uysal M; Koçak-Toker N
    Arch Physiol Biochem; 2017 Jul; 123(3):192-198. PubMed ID: 28276708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential.
    Faria A; Persaud SJ
    Pharmacol Ther; 2017 Apr; 172():50-62. PubMed ID: 27916650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.